Clinical trial
Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for…
NCT00187291 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00187291 |
|---|---|
| Title | Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life-threatening Heart Rhythms (ABCD Study) |
| Official title | Alternans Before Cardioverter Defibrillator (ABCD) Trial |
| Lead sponsor | Abbott Medical Devices, Industry |
| Collaborators | Cambridge Heart Inc. Industry MetroHealth Medical Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ischemic Cardiomyopathy, LV Dysfunction |
| Intervention type | Device |
| Interventions | T-Wave Alternans test |
| Enrollment | 618 |
| Start date | Apr 1, 2001 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 13, 2023 |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: